LON:MTPHMidatech Pharma Share Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Midatech Pharma PLC Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add GBX 31.50 -2.00 (-5.97 %) (As of 07/14/2020) Add Compare Share Today's Range 30.16Now: GBX 31.50▼ 33.5050-Day Range 19.25MA: GBX 25.46▼ 86.5052-Week Range 0.19Now: GBX 31.50▼ 87Volume424,713 shsAverage Volume61,863 shsMarket Capitalization£12.36 millionP/E RatioN/ADividend YieldN/ABetaN/A ProfileAdvanced ChartCompetitorsEarningsInsider TradesHeadlines Midatech Pharma PLC, a specialty pharmaceutical company, focuses on developing and commercializing products in oncology and immunotherapy in the United States and the United Kingdom. The company operates through two segments, Pipeline Research and Development; and Commercial. Its products include Zuplenz, an oral soluble film for moderately emetogenic chemotherapy-induced nausea and vomiting, radiotherapy-induced nausea and vomiting, and post-operative nausea and vomiting; Gelclair, an oral gel barrier device indicated for the management and relief of pain due to oral mucositis; Oravig, an orally dissolving buccal tablet for oral thrush; and Soltamox, an oral liquid solution of tamoxifen citrate, for the treatment and prevention of breast cancer. Midatech Pharma PLC is collaborating with universities and pharmaceutical companies to develop its platform technologies into a range of products. Midatech Pharma PLC was founded in 2000 and is headquartered in Abingdon, the United Kingdom.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for Midatech Pharma. Previous Next 3.3 Community Rank Outperform VotesMidatech Pharma has received 242 “outperform” votes. (Add your “outperform” vote.)Underperform VotesMidatech Pharma has received 125 “underperform” votes. (Add your “underperform” vote.)Community SentimentMidatech Pharma has received 65.94% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Midatech Pharma and other stocks. Vote “Outperform” if you believe MTPH will outperform the S&P 500 over the long term. Vote “Underperform” if you believe MTPH will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldMidatech Pharma does not currently pay a dividend.Dividend GrowthMidatech Pharma does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Midatech Pharma insiders have not sold or bought any company stock. Previous Next 0.6 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Midatech Pharma is -0.57, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Midatech Pharma is -0.57, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioMidatech Pharma has a P/B Ratio of 0.38. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Previous Next Analyst Opinion: 0.0Community Rank: 3.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -Overall Beat the Market Rank™0.79 out of 5 stars Industry, Sector and Symbol Stock Exchange LON Industry Biotechnology Sub-IndustryN/A SectorMedical Current SymbolLON:MTPH Previous Symbol CUSIPN/A CIKN/A Webwww.midatechpharma.com Phone+44-1235-841575Debt Debt-to-Equity Ratio35.74 Current Ratio2.42 Quick Ratio2.40Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales£674,000.00 Price / Sales18.35 Cash FlowGBX 20.36 per share Price / Cash Flow1.55 Book ValueGBX 83.30 per share Price / Book0.38Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees73 Outstanding Shares39,252,600Market Cap£12.36 million Next Earnings DateN/A OptionableNot Optionable GBX 31.50 -2.00 (-5.97 %) (As of 07/14/2020) 30 days | 90 days | 365 days | Advanced Chart Receive MTPH News and Ratings via Email Sign-up to receive the latest news and ratings for MTPH and its competitors with MarketBeat's FREE daily newsletter. Midatech Pharma (LON:MTPH) Frequently Asked Questions How has Midatech Pharma's stock been impacted by COVID-19 (Coronavirus)? Midatech Pharma's stock was trading at GBX 36 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, MTPH shares have decreased by 12.5% and is now trading at GBX 31.50. View which stocks have been most impacted by Coronavirus. How were Midatech Pharma's earnings last quarter? Midatech Pharma PLC (LON:MTPH) released its earnings results on Tuesday, June, 16th. The company reported ($1,000.00) earnings per share (EPS) for the quarter. View Midatech Pharma's earnings history. Has Midatech Pharma been receiving favorable news coverage? News articles about MTPH stock have trended somewhat positive this week, InfoTrie reports. The research group identifies negative and positive media coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Midatech Pharma earned a coverage optimism score of 1.8 on InfoTrie's scale. They also assigned media coverage about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the company's share price in the immediate future. View the latest news about Midatech Pharma. Who are some of Midatech Pharma's key competitors? Some companies that are related to Midatech Pharma include Redx Pharma (REDX), OptiBiotix Health (OPTI), Memphasys (MEM), Zelda Therapeutics (ZLD), Armata Pharmaceuticals (ARMP), AmpliPhi Biosciences (ARMP), Botanix Pharmaceuticals (BOT), Can-Fite Biopharma (CANF), Race Oncology (RAC), ReNeuron Group (RENE), CAN-FITE BIOPHA/S (CANF), NovaBay Pharmaceuticals (NBY), Covalon Technologies (COV), ContraVir Pharmaceuticals (HEPA) and Hvivo (HVO). View all competitors. What other stocks do shareholders of Midatech Pharma own? Based on aggregate information from My MarketBeat watchlists, some companies that other Midatech Pharma investors own include Aldeyra Therapeutics (ALDX), Barclays (BARC), Telefonaktiebolaget LM Ericsson (ERIC), Futura Medical (FUM), Lloyds Banking Group (LLOY), Pearson (PSON), Royal Mail (RMG), AON (AON), Angus Energy (ANGS) and Advanced Medical Solutions Group (AMS). Who are Midatech Pharma's key executives? Midatech Pharma's management team includes the following people: Mr. Nicholas John Robbins-Cherry, CFO, Company Sec. & Director (Age 50)Dr. Craig Richard Cook, CEO, COO & Director (Age 52)Mr. Rob Rainey FCA MBA MA, Head of Corp. Devel.Dr. Tim Sparey Ph.D., Chief Bus. OfficerMr. Justin Barry BSc (Hons.), MBIOL, CBIOL, QP, Head of Manufacturing What is Midatech Pharma's stock symbol? Midatech Pharma trades on the London Stock Exchange (LON) under the ticker symbol "MTPH." How do I buy shares of Midatech Pharma? Shares of MTPH and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What is Midatech Pharma's stock price today? One share of MTPH stock can currently be purchased for approximately GBX 31.50. How big of a company is Midatech Pharma? Midatech Pharma has a market capitalization of £12.36 million and generates £674,000.00 in revenue each year. Midatech Pharma employs 73 workers across the globe. What is Midatech Pharma's official website? The official website for Midatech Pharma is www.midatechpharma.com. How can I contact Midatech Pharma? Midatech Pharma's mailing address is 65 Innovation Drive, Milton Park, ABINGDON, OX14 4RQ, United Kingdom. The company can be reached via phone at +44-1235-841575. This page was last updated on 8/4/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
